GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
279 hedge funds and large institutions have $2.75B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 83 reducing their positions, and 42 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
14% more capital invested
Capital invested by funds: $2.41B → $2.75B (+$344M)
5% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 42
0% more funds holding
Funds holding: 279 → 279 (0)
18% less call options, than puts
Call options by funds: $99.2M | Put options by funds: $121M
23% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 83
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$91.4M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$27.6M |
| 3 |
Renaissance Technologies
New York
|
+$7.73M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$7.57M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$52.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$34.6M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$25.8M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$15.5M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$14.6M |
GWPH Hedge Fund Activity: Q4 2020 in Review
279 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2020, worth a combined $2.75B — up 14% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new GWPH positions and 42 closed out — a net gain of 2 holders — while 64 added to existing stakes and 83 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $91.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $52.8M sold.
- 279 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $2.75B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2020, up 14% quarter-over-quarter.
- 44 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2020 and 42 closed out, a net change of +2 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2020 was Redmile Group, an estimated $91.4M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2020 was Point72 Asset Management, an estimated $52.8M sold.
Based on aggregated 13F filings for Q4 2020.